← Back to Clinical Trials
Recruiting NCT07492511

Renal and Hepatic Abnormal Doppler Patterns in Trauma

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Trauma (Including Fractures)
Sponsor Azienda Usl di Bologna
Study Type OBSERVATIONAL
Phase N/A
Enrollment 350
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2026-03-01
Completion 2029-12-31
Interventions
Point of care ultrasound

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to learn about renal and hepatic blood flow abnormalities detected by bedside ultrasound in adult patients admitted to the intensive care unit (ICU) following major trauma. The main questions it aims to answer are: * How reliably can trained operators measure renal Doppler and venous congestion scores (RDRI and VExUS) across different hospitals? * How common are abnormal kidney and liver blood flow patterns in major trauma patients during the first 72 hours of ICU admission? * Are these abnormal patterns associated with acute kidney injury or the need for mechanical ventilation? Participants admitted to ICUs or high-dependency units (HDUs) with major trauma (Injury Severity Score \>15) will undergo non-invasive bedside ultrasound assessments at admission and at 24, 48, and 72 hours. No additional treatments or interventions will be given as part of this study. Kidney function will also be checked at 6 months after hospital discharge.

Eligibility Criteria

Inclusion Criteria: * Age 18-65 years; * Admission within 24h from traumatic injury; * ISS \>15 Exclusion Criteria: 1. Age \<18 or \>65; 2. Known heart failure (NYHA ≥II); 3. Chronic kidney disease (any stage) or chronic RRT; 4. Chronic respiratory disease needing home O₂ or ventilation; 5. Radiological evidence of vascular or parenchymal renal injury on trauma CT precluding reliable Doppler assessment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}